Status:
COMPLETED
Chloroprocaine for Inguinal Herniorrhaphy
Lead Sponsor:
University Hospital, Ghent
Conditions:
Spinal Anesthesia
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This study is to determine the minimum effective dose for intrathecal chloroprocaine in inguinal herniorrhaphy in outpatients using a Combined Spinal Epidural (CSE) anesthesia.
Detailed Description
A standard CSE procedure will be conducted in which the patient is placed in an upright sitting position on the side of the operation table and a epidural Tuohy needle 18G will be inserted into L3-L4 ...
Eligibility Criteria
Inclusion
- Outpatients for unilateral inguinal hernia repair
- ASA I - II - III
Exclusion
- hypersensitivity to amino-ester local anesthetics, para-aminobenzoic acid or sufentanil
- contraindications to spinal or epidural anesthesia
- bilateral inguinal herniorrhaphy
- extremes of height and weight (BMI 20 or 35 kg/m2, height 150 cm or 185 cm)
Key Trial Info
Start Date :
September 16 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 4 2018
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT03805503
Start Date
September 16 2015
End Date
December 4 2018
Last Update
January 15 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.